The extracellular matrix in digestive cancer

Cancer Microenvironment

Volumn 3, Issue 1, 2010, Pages 177-185

  Worthley, Daniel L ^a,b   Giraud, Andrew S ^c   Wang, Timothy C ^d  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d NONE

Author keywords

Bone marrow derived cells; Cancer; Cancer stroma; Digestive system neoplasms; Extracellular matrix; Gastrointestinal cancer; Neoplasms

Indexed keywords

ABELSON KINASE; AE 941; ALPHA INTEGRIN; BETA INTEGRIN; COLLAGEN TYPE 4; COLLAGENASE 3; DALTEPARIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; INTEGRIN LINKED KINASE; INTERSTITIAL COLLAGENASE; K RAS PROTEIN; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAS PROTEIN; SCATTER FACTOR; TETRACYCLINE DERIVATIVE; VASCULOTROPIN;

BASEMENT MEMBRANE; CANCER INVASION; CARCINOGENESIS; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; DRUG TARGETING; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 78649682497     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-010-0053-4     Document Type: Conference Paper

References (93)

1. Worthley D, Giraud A, Wang T (2010) Stromal fibroblasts in digestive cancer. Cancer Microenvironment. In press.
2. MJ Bissell D Radisky 2001 Putting tumours in context Nat Rev Cancer 1 46 54 10.1038/35094059 11900251 1:STN:280:DC%2BD387mvVOhtw%3D%3D
3. R Kalluri M Zeisberg 2006 Fibroblasts in cancer Nat Rev Cancer 6 392 401 10.1038/nrc1877 16572188 1:CAS:528:DC%2BD28XjslGitLw%3D
4. C Gaggioli S Hooper C Hidalgo-Carcedo, et al. 2007 Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells Nat Cell Biol 9 1392 1400 10.1038/ncb1658 18037882 1:CAS:528:DC%2BD2sXhtlOns7bK (Pubitemid 350201752)
5. LA Liotta EC Kohn 2001 The microenvironment of the tumour-host interface Nature 411 375 379 10.1038/35077241 11357145 1:CAS:528:DC%2BD3MXktVSjs78%3D (Pubitemid 32467047)
6. CM Nelson MJ Bissell 2006 Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer Annu Rev Cell Dev Biol 22 287 309 10.1146/annurev.cellbio.22.010305.104315 16824016 1:CAS:528:DC%2BD28Xht1yjs7vF
7. MJ Bissell HG Hall G Parry 1982 How does the extracellular matrix direct gene expression? J Theor Biol 99 31 68 10.1016/0022-5193(82)90388-5 6892044 1:CAS:528:DyaL3sXht1eisQ%3D%3D (Pubitemid 13209096)
8. JL Coulombre AJ Coulombre 1971 Metaplastic induction of scales and feathers in the corneal anterior epithelium of the chick embryo Dev Biol 25 464 478 10.1016/0012-1606(71)90042-X 4936043 1:STN:280:DyaE3M3ot1ajtA%3D%3D
9. GR Cunha P Young K Christov, et al. 1995 Mammary phenotypic expression induced in epidermal cells by embryonic mammary mesenchyme Acta Anat (Basel) 152 195 204 10.1159/000147698 1:STN:280:DyaK28%2Fgs12jsA%3D%3D
10. LE Littlepage M Egeblad Z Werb 2005 Coevolution of cancer and stromal cellular responses Cancer Cell 7 499 500 10.1016/j.ccr.2005.05.019 15950897 1:CAS:528:DC%2BD2MXlslCgsr4%3D (Pubitemid 40799241)
11. D Radisky J Muschler MJ Bissell 2002 Order and disorder: the role of extracellular matrix in epithelial cancer Cancer Investig 20 139 153 10.1081/CNV-120000374 (Pubitemid 34151067)
12. DW Powell RC Mifflin JD Valentich SE Crowe JI Saada AB West 1999 Myofibroblasts. I. Paracrine cells important in health and disease Am J Physiol 277 C1 C9 10409103 1:CAS:528:DyaK1MXkslKgtLY%3D
13. P Simon-Assmann M Kedinger A De Arcangelis V Rousseau P Simo 1995 Extracellular matrix components in intestinal development Experientia 51 883 900 10.1007/BF01921739 7556570 1:CAS:528:DyaK2MXovVyqsbk%3D
14. D Schuppan M Schmid R Somasundaram, et al. 1998 Collagens in the liver extracellular matrix bind hepatocyte growth factor Gastroenterology 114 139 152 10.1016/S0016-5085(98)70642-0 9428228 1:CAS:528:DyaK1cXks1Sitw%3D%3D (Pubitemid 28020964)
15. Lodish H, Berk A, Kaiser C et al (2008) Integrating cells into tissues. In: Molecular cell biology, 6th edn. New York: Freeman
16. DG Huntsman F Carneiro FR Lewis, et al. 2001 Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations N Engl J Med 344 1904 1909 10.1056/NEJM200106213442504 11419427 1:CAS:528:DC%2BD3MXltFers7g%3D (Pubitemid 32553359)
17. JD Potter 1999 Colorectal cancer: molecules and populations J Natl Cancer Inst 91 916 932 10.1093/jnci/91.11.916 10359544 1:STN:280:DyaK1M3os1WjsQ%3D%3D
18. TL Chang K Ito TK Ko, et al. 2010 Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells Gastroenterology 138 255 265 10.1053/j.gastro.2009.08.044 19706291 1:CAS:528:DC%2BC3cXht1ajtro%3D e251-253
19. M Krishnan AB Singh JJ Smith, et al. 2010 HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability Oncogene 29 305 312 10.1038/onc.2009.324 19881542 1:CAS:528:DC%2BD1MXhtlers7bI
20. CH Yoon MJ Kim MJ Park, et al. 2010 Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells J Biol Chem 285 226 233 10.1074/jbc.M109.054189 19897486 1:CAS:528:DC%2BD1MXhs1SqsbbI
21. M Lioni P Brafford C Andl, et al. 2007 Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells Am J Pathol 170 709 721 10.2353/ajpath.2007.060343 17255337 1:CAS:528:DC%2BD2sXitlOltL0%3D (Pubitemid 47342407)
22. J Dowling QC Yu E Fuchs 1996 Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival J Cell Biol 134 559 572 10.1083/jcb.134.2.559 8707838 1:CAS:528:DyaK28XktlKju7c%3D (Pubitemid 26250721)
23. RG Rowe SJ Weiss 2009 Navigating ECM barriers at the invasive front: the cancer cell-stroma interface Annu Rev Cell Dev Biol 25 567 595 10.1146/annurev.cellbio.24.110707.175315 19575644 1:CAS:528:DC%2BD1MXhsVKisbjO
24. J Khoshnoodi V Pedchenko BG Hudson 2008 Mammalian collagen IV Microsc Res Tech 71 357 370 10.1002/jemt.20564 18219669 1:CAS:528:DC%2BD1cXmvVSntLc%3D (Pubitemid 351620858)
25. P Simon-Assmann P Simo F Bouziges K Haffen M Kedinger 1990 Synthesis of basement membrane proteins in the small intestine Digestion 46 Suppl 2 12 21 10.1159/000200362 2124555 1:CAS:528:DyaK3MXlvFGlsQ%3D%3D
26. VA McLin SJ Henning M Jamrich 2009 The role of the visceral mesoderm in the development of the gastrointestinal tract Gastroenterology 136 2074 2091 10.1053/j.gastro.2009.03.001 19303014 1:CAS:528:DC%2BD1MXotVeqtLs%3D
27. DW Powell PA Adegboyega JF Di Mari RC Mifflin 2005 Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer Am J Physiol Gastrointest Liver Physiol 289 G2 G7 10.1152/ajpgi.00075. 2005 15961883 1:CAS:528:DC%2BD2MXmvVeru7g%3D (Pubitemid 40944217)
28. RO Hynes KM Yamada 1982 Fibronectins: multifunctional modular glycoproteins J Cell Biol 95 369 377 10.1083/jcb.95.2.369 6128348 1:CAS:528:DyaL38XmtFSls7s%3D (Pubitemid 13215850)
29. RO Hynes 2009 The extracellular matrix: not just pretty fibrils Science 326 1216 1219 10.1126/science.1176009 19965464 1:CAS:528:DC%2BD1MXhsVKhur%2FM
30. R Xu A Boudreau MJ Bissell 2009 Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices Cancer Metastasis Rev 28 167 176 10.1007/s10555-008-9178-z 19160017
31. FG Giancotti E Ruoslahti 1999 Integrin signaling Science 285 1028 1032 10.1126/science.285.5430.1028 10446041 1:CAS:528:DyaK1MXlt1Gns7o%3D (Pubitemid 29385945)
32. D Bray MD Levin CJ Morton-Firth 1998 Receptor clustering as a cellular mechanism to control sensitivity Nature 393 85 88 10.1038/30018 9590695 1:CAS:528:DyaK1cXjt1als7k%3D (Pubitemid 28240260)
33. MA Schwartz RK Assoian 2001 Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways J Cell Sci 114 2553 2560 11683383 1:CAS:528:DC%2BD3MXlvFSltr4%3D
34. A Danilkovitch S Donley A Skeel EJ Leonard 2000 Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells Mol Cell Biol 20 2218 2227 10.1128/MCB.20.6.2218-2227.2000 10688668 1:CAS:528:DC%2BD3cXhsVKmtrc%3D (Pubitemid 30123837)
35. H Gille J Downward 1999 Multiple ras effector pathways contribute to G(1) cell cycle progression J Biol Chem 274 22033 22040 10.1074/jbc.274.31.22033 10419529 1:CAS:528:DyaK1MXltVymtbg%3D (Pubitemid 29360044)
36. N Takuwa Y Fukui Y Takuwa 1999 Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts Mol Cell Biol 19 1346 1358 9891068 1:CAS:528:DyaK1MXhtVKhtbw%3D
37. SM Frisch RA Screaton 2001 Anoikis mechanisms Curr Opin Cell Biol 13 555 562 10.1016/S0955-0674(00)00251-9 11544023 1:CAS:528:DC%2BD3MXmsFersLs%3D (Pubitemid 32817013)
38. H Puthalakath A Villunger LA O'Reilly, et al. 2001 Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis Science 293 1829 1832 10.1126/science.1062257 11546872 1:CAS:528:DC%2BD3MXmvVSks7c%3D (Pubitemid 32845780)
39. Z Liu H Li M Derouet, et al. 2006 Oncogenic ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm J Biol Chem 281 14738 14747 10.1074/jbc.M508664200 16461771 1:CAS:528:DC%2BD28XkslGqsLk%3D (Pubitemid 43855179)
40. K Boisvert-Adamo AE Aplin 2008 Mutant B-RAF mediates resistance to anoikis via Bad and Bim Oncogene 27 3301 3312 10.1038/sj.onc.1211003 18246127 1:CAS:528:DC%2BD1cXmtFGnsr0%3D (Pubitemid 351733396)
41. A Katsumi AW Orr E Tzima MA Schwartz 2004 Integrins in mechanotransduction J Biol Chem 279 12001 12004 10.1074/jbc.R300038200 14960578 1:CAS:528:DC%2BD2cXitl2htb4%3D (Pubitemid 38445760)
42. MJ Paszek N Zahir KR Johnson, et al. 2005 Tensional homeostasis and the malignant phenotype Cancer Cell 8 241 254 10.1016/j.ccr.2005.08.010 16169468 1:CAS:528:DC%2BD2MXhtV2gt7vO (Pubitemid 41317594)
43. AL Berrier KM Yamada 2007 Cell-matrix adhesion J Cell Physiol 213 565 573 10.1002/jcp.21237 17680633 1:CAS:528:DC%2BD2sXht12jtbbE (Pubitemid 350058247)
44. CM Lo HB Wang M Dembo YL Wang 2000 Cell movement is guided by the rigidity of the substrate Biophys J 79 144 152 10.1016/S0006-3495(00)76279-5 10866943 1:CAS:528:DC%2BD3cXks1Klurc%3D
45. PJ Wipff B Hinz 2008 Integrins and the activation of latent transforming growth factor beta1-an intimate relationship Eur J Cell Biol 87 601 615 10.1016/j.ejcb.2008.01.012 18342983 1:CAS:528:DC%2BD1cXht1Ciu7fN
46. AC Chiang J Massague 2008 Molecular basis of metastasis N Engl J Med 359 2814 2823 10.1056/NEJMra0805239 19109576 1:CAS:528:DC%2BD1cXhsFCnt7bF
47. K Ikeda K Iyama N Ishikawa, et al. 2006 Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region Am J Pathol 168 856 865 10.2353/ajpath.2006.050384 16507901 1:CAS:528:DC%2BD28XislGgtbo%3D (Pubitemid 43327738)
48. S Spaderna O Schmalhofer F Hlubek, et al. 2006 A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer Gastroenterology 131 830 840 10.1053/j.gastro.2006.06.016 16952552 1:CAS:528:DC%2BD28XhtVKrurnP (Pubitemid 44307069)
49. N Bechetoille M Haftek MJ Staquet AJ Cochran D Schmitt O Berthier-Vergnes 2000 Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII Melanoma Res 10 427 434 10.1097/00008390-200010000-00004 11095403 1:CAS:528:DC%2BD3cXosFShtL0%3D
50. M Franz P Richter C Geyer, et al. 2007 Mesenchymal cells contribute to the synthesis and deposition of the laminin-5 gamma2 chain in the invasive front of oral squamous cell carcinoma J Mol Histol 38 183 190 10.1007/s10735-007- 9086-5 17390227 1:CAS:528:DC%2BD2sXls1Sgurs%3D (Pubitemid 46980551)
51. PM Comoglio L Trusolino 2005 Cancer: the matrix is now in control Nat Med 11 1156 1159 10.1038/nm1105-1156 16270068 1:CAS:528:DC%2BD2MXhtFOhsL3L (Pubitemid 43093657)
52. JH McKerrow V Bhargava E Hansell, et al. 2000 A functional proteomics screen of proteases in colorectal carcinoma Mol Med 6 450 460 10952024 1:CAS:528:DC%2BD3cXmtVakurY%3D
53. MD Sternlicht Z Werb 2001 How matrix metalloproteinases regulate cell behavior Annu Rev Cell Dev Biol 17 463 516 10.1146/annurev.cellbio.17.1.463 11687497 1:CAS:528:DC%2BD3MXos1Omsbs%3D (Pubitemid 33096184)
54. KB Hotary I Yana F Sabeh, et al. 2002 Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes J Exp Med 195 295 308 10.1084/jem.20010815 11828004 1:CAS:528:DC%2BD38Xht1Wjt78%3D (Pubitemid 34461487)
55. F Sabeh I Ota K Holmbeck, et al. 2004 Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP J Cell Biol 167 769 781 10.1083/jcb.200408028 15557125 1:CAS:528: DC%2BD2cXhtVaqtb3J (Pubitemid 39565156)
56. M Morini M Mottolese N Ferrari, et al. 2000 The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity Int J Cancer 87 336 342 10.1002/1097-0215(20000801)87: 3<336::AID-IJC5>3.0.CO;2-3 10897037 1:CAS:528:DC%2BD3cXltFOnsLs%3D (Pubitemid 30451643)
57. PC Brooks S Stromblad LC Sanders, et al. 1996 Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 Cell 85 683 693 10.1016/S0092-8674(00)81235-0 8646777 1:CAS:528:DyaK28Xjtlyls78%3D (Pubitemid 26181048)
58. K Hotary XY Li E Allen SL Stevens SJ Weiss 2006 A cancer cell metalloprotease triad regulates the basement membrane transmigration program Genes Dev 20 2673 2686 10.1101/gad.1451806 16983145 1:CAS:528:DC%2BD28XhtV2hsLvE (Pubitemid 44498378)
59. SE Perez DA Cano T Dao-Pick JP Rougier Z Werb M Hebrok 2005 Matrix metalloproteinases 2 and 9 are dispensable for pancreatic islet formation and function in vivo Diabetes 54 694 701 10.2337/diabetes.54.3.694 15734845 1:CAS:528:DC%2BD2MXitlegsrk%3D (Pubitemid 40322071)
60. C Bendrik J Robertson J Gauldie C Dabrosin 2008 Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo Cancer Res 68 3405 3412 10.1158/0008-5472.CAN-08-0295 18451168 1:CAS:528: DC%2BD1cXltlSltr4%3D
61. S Cheng AS Pollock R Mahimkar JL Olson DH Lovett 2006 Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury FASEB J 20 1898 1900 10.1096/fj.06-5898fje 16891619 1:CAS:528:DC%2BD28XptlOmsbw%3D (Pubitemid 44933772)
62. T Itoh M Tanioka H Yoshida T Yoshioka H Nishimoto S Itohara 1998 Reduced angiogenesis and tumor progression in gelatinase A-deficient mice Cancer Res 58 1048 1051 9500469 1:CAS:528:DyaK1cXhsFersLo%3D
63. MD Sternlicht A Lochter CJ Sympson, et al. 1999 The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis Cell 98 137 146 10.1016/S0092-8674(00)81009-0 10428026 1:CAS:528:DyaK1MXltVOqt7o%3D (Pubitemid 29344902)
64. DC Radisky DD Levy LE Littlepage, et al. 2005 Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability Nature 436 123 127 10.1038/nature03688 16001073 1:CAS:528:DC%2BD2MXlvVGiurk%3D (Pubitemid 40966197)
65. K List R Szabo A Molinolo, et al. 2005 Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation Genes Dev 19 1934 1950 10.1101/gad.1300705 16103220 1:CAS:528:DC%2BD2MXpsFCqs74%3D (Pubitemid 41186993)
66. S Linder 2009 Invadosomes at a glance J Cell Sci 122 3009 3013 10.1242/jcs.032631 19692587 1:CAS:528:DC%2BD1MXht1Wksb%2FM
67. R Poincloux F Lizarraga P Chavrier 2009 Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia J Cell Sci 122 3015 3024 10.1242/jcs.034561 19692588 1:CAS:528:DC%2BD1MXht1Wksb%2FN
68. K Wolf P Friedl 2009 Mapping proteolytic cancer cell-extracellular matrix interfaces Clin Exp Metastasis 26 289 298 10.1007/s10585-008-9190-2 18600304 1:CAS:528:DC%2BD1MXivFyhtb4%3D
69. K Yamada E Cukierman 2007 Modeling tissue morphogenesis and cancer in 3D Cell 130 601 610 10.1016/j.cell.2007.08.006 17719539 1:CAS:528: DC%2BD2sXhtVels77F (Pubitemid 47268064)
70. HK Kleinman GR Martin 2005 Matrigel: basement membrane matrix with biological activity Semin Cancer Biol 15 378 386 10.1016/j.semcancer.2005.05.004 15975825 1:CAS:528:DC%2BD2MXnslyjuro%3D (Pubitemid 41140305)
71. S Futaki Y Hayashi M Yamashita, et al. 2003 Molecular basis of constitutive production of basement membrane components. Gene expression profiles of Engelbreth-Holm-Swarm tumor and F9 embryonal carcinoma cells J Biol Chem 278 50691 50701 10.1074/jbc.M304985200 12968032 1:CAS:528: DC%2BD3sXpslSqu74%3D (Pubitemid 37548918)
72. R Fridman MC Kibbey LS Royce, et al. 1991 Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel J Natl Cancer Inst 83 769 774 10.1093/jnci/83.11.769 1789823 1:STN:280:DyaK3M3ltFWmsA%3D%3D
73. S Vukicevic HK Kleinman FP Luyten AB Roberts NS Roche AH Reddi 1992 Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components Exp Cell Res 202 1 8 10.1016/0014-4827(92)90397-Q 1511725 1:CAS:528:DyaK38Xls1Cku7s%3D
74. JA Reuter S Ortiz-Urda M Kretz, et al. 2009 Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression Cancer Cell 15 477 488 10.1016/j.ccr.2009.04.002 19477427 1:CAS:528:DC%2BD1MXntlegtbw%3D
75. S Siena A Sartore-Bianchi F Di Nicolantonio J Balfour A Bardelli 2009 Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer J Natl Cancer Inst 101 1308 1324 10.1093/jnci/djp280 19738166 1:CAS:528:DC%2BD1MXht1Ojt73I
76. KP Olive MA Jacobetz CJ Davidson, et al. 2009 Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 1457 1461 10.1126/science.1171362 19460966 1:CAS:528:DC%2BD1MXntVSiu7Y%3D
77. XH Yang LM Flores Q Li, et al. 2010 Disruption of Laminin-Integrin-CD151- Focal Adhesion Kinase Axis Sensitizes Breast Cancer Cells to ErbB2 Antagonists Cancer Res 70 2256 2263 10.1158/0008-5472.CAN-09-4032 20197472 1:CAS:528:DC%2BC3cXjtFygt70%3D
78. S Ning JA Nemeth RL Hanson K Forsythe SJ Knox 2008 Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivo Mol Cancer Ther 7 1569 1578 10.1158/1535-7163.MCT-08- 0288 18566227 1:CAS:528:DC%2BD1cXnsVSktb4%3D
79. AR Hsu A Veeravagu W Cai LC Hou V Tse X Chen 2007 Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment Recent Pat Anticancer Drug Discov 2 143 158 10.2174/157489207780832469 18221059 1:CAS:528: DC%2BD2sXntlCqs7c%3D
80. JA Nemeth MT Nakada M Trikha, et al. 2007 Alpha-v integrins as therapeutic targets in oncology Cancer Investig 25 632 646 10.1080/ 07357900701522638 1:CAS:528:DC%2BD2sXhtlWku7nJ (Pubitemid 350135743)
81. X Lu D Lu M Scully V Kakkar 2008 The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy Perspect Med Chem 2 57 73 1:CAS:528:DC%2BD1cXhtVWrsLzE
82. R Roy J Yang MA Moses 2009 Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer J Clin Oncol 27 5287 5297 10.1200/JCO.2009.23.5556 19738110 1:CAS:528:DC%2BD1MXhsFahsLnP
83. M Tian YZ Cui GH Song, et al. 2008 Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients BMC Cancer 8 241 10.1186/1471-2407-8-241 18706098 1:CAS:528:DC%2BD1cXhtVygs7fE
84. M Yokoyama K Ochi M Ichimura, et al. 2002 Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer Pancreas 24 344 347 10.1097/00006676-200205000-00004 11961486 (Pubitemid 34441914)
85. KF Kuhlmann JW van Till MA Boermeester, et al. 2007 Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer Cancer Epidemiol Biomark Prev 16 886 891 10.1158/1055-9965.EPI-06-0779 1:CAS:528:DC%2BD2sXltlWgsbc%3D (Pubitemid 46910086)
86. LE Jones MJ Humphreys F Campbell JP Neoptolemos MT Boyd 2004 Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival Clin Cancer Res 10 2832 2845 10.1158/1078-0432.CCR-1157-03 15102692 1:CAS:528:DC%2BD2cXjt1Clur8%3D (Pubitemid 38509163)
87. M Hilska PJ Roberts YU Collan, et al. 2007 Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer Int J Cancer 121 714 723 10.1002/ijc.22747 17455256 1:CAS:528:DC%2BD2sXotleqtbo%3D (Pubitemid 47106199)
88. S Koskensalo J Mrena JP Wiksten, et al. 2010 MMP-7 overexpression is an independent prognostic marker in gastric cancer Tumour Biol 31 149 155 10.1007/s13277-010-0020-1 20300917 1:CAS:528:DC%2BC3cXmslektrg%3D
89. MG Tutton ML George SA Eccles S Burton RI Swift AM Abulafi 2003 Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients Int J Cancer 107 541 550 10.1002/ijc.11436 14520690 1:CAS:528:DC%2BD3sXoslequ7s%3D (Pubitemid 37296113)
90. J Latreille G Batist F Laberge, et al. 2003 Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer Clin Lung Cancer 4 231 236 10.3816/CLC.2003.n.003 14624712 1:CAS:528:DC%2BD3sXmvFWntLY%3D
91. G Batist F Patenaude P Champagne, et al. 2002 Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels Ann Oncol 13 1259 1263 10.1093/annonc/mdf195 12181250 1:STN:280:DC%2BD38visVeqtA%3D%3D (Pubitemid 34960135)
92. K Sideras PL Schaefer SH Okuno, et al. 2006 Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial Mayo Clin Proc 81 758 767 10.4065/81.6.758 16770976 1:CAS:528:DC%2BD28XmtVOmt7k%3D
93. JB Finkelstein 2005 Sharks do get cancer: few surprises in cartilage research J Natl Cancer Inst 97 1562 1563 10.1093/jnci/dji392 16264172 (Pubitemid 41662706)